 |
 |

Recalcitrant Symptomatic Vulvar Lichen Planus
Response to Topical Tacrolimus
Julie A. Byrd, MD;
Mark D. P. Davis, MD;
Roy S. Rogers III, MD
Arch Dermatol. 2004;140:715-720.
Background Topical tacrolimus has been reported to be an effective treatment for genital lichen planus in small case series. We retrospectively reviewed the medical records of 16 patients with symptomatic vulvar lichen planus who received treatment with tacrolimus ointment.
Observations All patients had symptomatic vulvar lichen planus recalcitrant to other treatments. Of 16 patients, 15 (94%) experienced a symptomatic response to tacrolimus treatment within 3 months (mean, 4.2 weeks) and had a partial or complete resolution of the lesions. Six patients (38%) reported mild adverse effects, including irritation, burning, and tingling. With continued use of the medication, these adverse effects resolved. When patients stopped treatment, lichen planus returned in 10 (83%) of 12 patients within 6 months after discontinuation of therapy (median, 1 week; range, 0.3-24 weeks), but in 6 patients the lesions were less severe than the lesions before treatment; all 10 patients resumed use of topical tacrolimus.
Conclusions In this retrospective series of 16 women with vulvar lichen planus, topical tacrolimus therapy effectively controlled symptoms and improved lesions in all but 1 patient. The effect may be temporary, requiring continued use of tacrolimus, which appears to be safe and effective in controlling disease activity.
From the Department of Dermatology, Mayo Clinic, Rochester, Minn. The authors have no relevant financial interest in this article.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Vulvovaginal Lichen Planus: A Disease in Need of a Unified Approach
Neill and Lewis
Arch Dermatol 2008;144:1502-1503.
FULL TEXT
New and Old Therapeutics for Oral Ulcerations
Bruce and Rogers
Arch Dermatol 2007;143:519-523.
FULL TEXT
Response of Oral Lichen Planus to Topical Tacrolimus in 37 Patients
Byrd et al.
Arch Dermatol 2004;140:1508-1512.
ABSTRACT
| FULL TEXT
|